<p><b>(a)</b> Equilibria for rapid reversible inhibition via a one-step mechanism and slow-binding inhibition via a two-step induced-fit mechanism along with a schematic free-energy profile for this reaction. E denotes the enzyme, I the inhibitor, EI the initial enzyme-inhibitor complex, and EI* the final enzyme-inhibitor complex. In the case of InhA, the diphenyl ether inhibitors bind to the enzyme with bound oxidized cofactor NAD<sup>+</sup>, forming a ternary complex. The double-headed arrows in the energy profile highlight the importance of the barrier height for the kinetics of the reaction. <b>(b)</b> Schematic free-energy profiles for a slow-binding inhibitor (left) and a destabilized EI* state as a consequence of ligand removal or t...
262-273Developing free energy estimates of biological molecules starting from a molecular descript...
An important kinetic parameter for drug efficacy is the residence time of a compound at a drug targe...
<div><p>An important kinetic parameter for drug efficacy is the residence time of a compound at a dr...
A critical goal of lead compound selection and optimization is to maximize target engagement while m...
A critical goal of lead compound selection and optimization is to maximize target engagement while m...
<p>One-step binding: the inhibitor [I] and substrate [S] are in equilibrium; binding is competitive ...
<p><i>A, B</i> = First and second substrate of enzyme <i>E</i>; <i>P, Q</i> = First and second sub...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...
Reproducibility of biological data is a significant problem in research today. One potential contrib...
<p>A) Relative to NADPH, e29 is an uncompetitive inhibitor of the purified <i>Y. pestis</i> MEP synt...
The mathematics and geometry of the "kobs" method under the tight-binding experimental conditions, w...
The inhibition of glycoside hydrolases, through transition-state mimicry, is important both as a pro...
An important kinetic parameter for drug efficacy is the residence time of a compound at a drug targe...
Enzymes are proteins that catalyse biochemical reactions in living organisms. They play critical rol...
262-273Developing free energy estimates of biological molecules starting from a molecular descript...
An important kinetic parameter for drug efficacy is the residence time of a compound at a drug targe...
<div><p>An important kinetic parameter for drug efficacy is the residence time of a compound at a dr...
A critical goal of lead compound selection and optimization is to maximize target engagement while m...
A critical goal of lead compound selection and optimization is to maximize target engagement while m...
<p>One-step binding: the inhibitor [I] and substrate [S] are in equilibrium; binding is competitive ...
<p><i>A, B</i> = First and second substrate of enzyme <i>E</i>; <i>P, Q</i> = First and second sub...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...
Reproducibility of biological data is a significant problem in research today. One potential contrib...
<p>A) Relative to NADPH, e29 is an uncompetitive inhibitor of the purified <i>Y. pestis</i> MEP synt...
The mathematics and geometry of the "kobs" method under the tight-binding experimental conditions, w...
The inhibition of glycoside hydrolases, through transition-state mimicry, is important both as a pro...
An important kinetic parameter for drug efficacy is the residence time of a compound at a drug targe...
Enzymes are proteins that catalyse biochemical reactions in living organisms. They play critical rol...
262-273Developing free energy estimates of biological molecules starting from a molecular descript...
An important kinetic parameter for drug efficacy is the residence time of a compound at a drug targe...
<div><p>An important kinetic parameter for drug efficacy is the residence time of a compound at a dr...